Latest Breaking News On - Avidity partners - Page 3 : comparemela.com

ARCA biopharma and Oruka Therapeutics Announce Merger Agreement

ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesWedbush pacgrowFairjourney biologicsRoberte conwayJeff dekkerSamarth kulkarniAndrew blauveltLawrence kleinPeter harwinCarl dambkowskiWilson sonsini goodrich rosatiParagon therapeutics incExchange commissionOruka therapeutics corporate communications contactRedmile groupOruka therapeutics inc

Announces Oversubscribed Private Placement of U S $150 Million

Announces Oversubscribed Private Placement of U S $150 Million
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesCybin incHaywood securities incShelf prospectusOntario securities commissionHealth canadaBloom burton securities incDrug administrationCompany the commonExchange commissionOversubscribed private placementCommon sharePrivate placementDeep track capitalAvidity partners

Cybin Inc (CYBN) Announces $150M Oversubscribed Private Placement at $0 43/sh

Cybin Inc (CYBN) Announces $150M Oversubscribed Private Placement at $0 43/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCompany the commonDrug administrationExchange commissionOntario securities commissionShelf prospectusHaywood securities incCybin incBloom burton securities incCommon sharePrivate placementDeep track capitalAvidity partnersAcorn bioventuresAltium capitalLogos capital

Immunic, Inc (NASDAQ:IMUX) Q4 2023 Earnings Call Transcript

Immunic, Inc. beats earnings expectations. Reported EPS is $-0.48, expectations were $-0.51.

United statesNoord hollandGeertr dhaensFranziska burianekBob foxDaniel vittJessica breuGlenn whaleyImmunic incAssembly conferenceAssociation of european celiac societyAmsterdam university medical centerCall transcript februaryFourth quarterYear endVice president

Immunic, Inc Reports Year End 2023 Financial Results and Provides Corporate Update

– Significantly Strengthened Balance Sheet in January 2024 with Execution of Three-Tranche Private Placement of up to $240 Million, Extending Cash Runway Into the Third Quarter of 2025 Based on.

United statesEdna kaplanPaula schwartzJessica breuDaniel vittImmunic incAssembly conferenceExchange commissionDevelopment rd expensesRx communications groupAssociation of european coeliac societiesProgram in relapsing multiple sclerosis ongoingTrademark officeSignificantly strengthened balance sheetThree tranche private placementExtending cash runway into